Tag: GSK
GSK: Success of a phase 3 trial with Jemperli
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
GSK: Strategic agreement with Cytel in clinical trials
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Antibiotics: the GSK factory in Mayenne is working hard in the face of shortages
The GSK pharmaceutical factory in Mayenne, January 5, 2023 (AFP / JEAN-FRANCOIS MONIER) To cope with shortages affecting certain major antibiotics, the British laboratory GSK is working hard at its…
GSK: License agreement with the Chinese WuXi Bio
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
GSK: license agreement with Chinese WuXi Bio
(CercleFinance.com) – The Chinese pharmaceutical subcontractor WuXi Biologics announced on Thursday the signing of a license agreement with GSK, which will have the possibility to exercise up to four options…
GSK: Strategic collaboration with Wave Life Sciences
(CercleFinance.com) – GSK announces a strategic collaboration with Wave Life Sciences, a clinical-stage genetic drug company, to advance oligonucleotide therapies. GSK reminds that oligonucleotides are short strands of DNA or…
GSK: Headquarters will move to central London
(CercleFinance.com) – GSK announced on Monday its intention to move its headquarters to central London, where it will accommodate 3,000 employees, including employees of certain subsidiaries. The British pharmaceutical group,…
Sanofi: GSK, Pfizer, Sanofi win legal victory over Zantac
(Reuters) – Thousands of U.S. federal lawsuits against pharmaceutical companies GSK, Pfizer, Sanofi and Boehringer Ingelheim linking stomach acid drug Zantac to cancer were dismissed in court on Tuesday from…
GSK: primary endpoint achieved in endometrial cancer
(CercleFinance.com) – GSK announced on Friday that Jemperli has reached its primary endpoint in a phase III clinical study in the treatment of endometrial cancer. The UK pharma company says…
GSK: asks the EMA to market momelotinib
(CercleFinance.com) – The GSK laboratory announces today that it has applied to the European Medicines Agency (EMA) for a request for marketing authorization (MA) for momelotinib, a potential new oral…
GSK: positive results for an experimental tuberculosis drug
(CercleFinance.com) – GSK today announced positive results from a phase IIa study demonstrating that GSK3036656, a first-in-class investigational anti-tuberculosis agent, was ‘well tolerated’ and exhibited ‘early bactericidal activity when administered…
The European Commission approves the booster vaccine against Covid-19 from Sanofi and GSK – 10/11/2022 at 18:29
(AOF) – In accordance with the favorable opinion delivered by the Committee for Medicinal Products for Human Use (CHMP, Committee for Medicinal Products for Human Use) of the European Medicines…